Merck EVP granted options and RSUs

Merck & Co., Inc. reported that EVP, Specialty, Pharma, & ID Brian Foard received new equity awards.

Rhea-AI Filing Summary

Merck & Co., Inc. reported that EVP, Specialty, Pharma, & ID Brian Foard received new equity awards. On May 5, 2026, he was granted a stock option covering 31,044 shares of common stock with an exercise price of $113.15 per share, vesting in three equal annual installments on May 5 of 2027, 2028, and 2029.

He was also granted restricted stock units for 35,351 shares and an additional 10,605 shares. Each restricted stock unit represents a contingent right to receive one share of Merck common stock and vests, with shares distributed, in three equal installments on May 5, 2027, May 5, 2028, and May 5, 2029. These are compensation grants, not open-market purchases or sales.

Insider Trade Summary

Grant/Award: 77,000 shares

Grant/Award 3 txns

Insider Foard Brian

Role EVP, Specialty, Pharma, & ID

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	10,605	$0.00	$0.00
Grant/Award	Restricted Stock Unit	35,351	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	31,044	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 45,956 contracts (Direct); Stock Option (Right to Buy) — 31,044 contracts (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
2. F2. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
3. F3. The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.

Key Figures

Stock options granted: 31,044 shares Option exercise price: $113.15 per share Primary RSU grant: 35,351 units +4 more

7 metrics

Stock options granted 31,044 shares Stock Option (Right to Buy) granted May 5, 2026

Option exercise price $113.15 per share Exercise price for 31,044-share option grant

Primary RSU grant 35,351 units Restricted Stock Units granted May 5, 2026

Additional RSU grant 10,605 units Additional Restricted Stock Units granted May 5, 2026

RSU conversion ratio 1 share per unit Each RSU equals one share of Merck common stock

Option vesting period 2027–2029 Option vests in equal installments on May 5, 2027–2029

RSU vesting dates May 5, 2027–2029 RSUs vest and settle in three equal annual installments

Key Terms

Stock Option (Right to Buy), Restricted Stock Unit, contingent right, vests and becomes exercisable, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Restricted Stock Unit financial

"security_title: Restricted Stock Unit"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"represents a contingent right to receive one share"

vests and becomes exercisable financial

"The option vests and becomes exercisable in equal installments"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Merck (MRK) grant to EVP Brian Foard?

Merck granted EVP Brian Foard a stock option for 31,044 shares at an exercise price of $113.15, plus restricted stock units for 35,351 and 10,605 shares. These awards provide future rights to Merck common stock, subject to vesting.

What is the vesting schedule for Brian Foard’s Merck (MRK) stock options?

Brian Foard’s stock option for 31,044 shares vests in three equal installments on May 5, 2027, May 5, 2028, and May 5, 2029. Once vested, the option becomes exercisable at the fixed $113.15 per-share price.

When do Brian Foard’s Merck (MRK) restricted stock units vest and settle?

His restricted stock units, covering 35,351 and 10,605 shares, vest and are distributed as Merck common stock in three equal installments on May 5, 2027, May 5, 2028, and May 5, 2029, subject to continued eligibility under award terms.

What does each restricted stock unit represent for Merck (MRK) awards?

Each restricted stock unit granted to Brian Foard represents a contingent right to receive one share of Merck & Co., Inc. common stock. He receives actual shares only as units vest and are distributed on the specified installment dates.

Are Brian Foard’s Merck (MRK) Form 4 transactions market buys or sells?

No. The Form 4 shows grant/award acquisitions of stock options and restricted stock units, all coded as transaction type “A.” These are compensation-related equity awards and do not reflect open-market purchases or sales of Merck shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 11:48 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foard Brian

(Last) (First) (Middle)

126 EAST LINCOLN AVENUE

(Street)

RAHWAY NEW JERSEY 07065

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Merck & Co., Inc. [ MRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Specialty, Pharma, & ID

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	05/05/2026		A		10,605		05/05/2027(2)	05/05/2029	Common Stock	10,605	$0	10,605	D
Restricted Stock Unit	(1)	05/05/2026		A		35,351		05/05/2027(2)	05/05/2029	Common Stock	35,351	$0	35,351	D
Stock Option (Right to Buy)	$113.15	05/05/2026		A		31,044		05/05/2027(3)	05/04/2036	Common Stock	31,044	$0	31,044	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

2. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.

3. The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.

	/s/ Kelly E. Grez as Attorney-in-Fact for Brian Foard	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)